Afzelin exhibits anti-cancer activity against androgen-sensitive LNCaP and androgen-independent PC-3 prostate cancer cells through the inhibition of LIM domain kinase 1. | |
Zhu Kai-Chang; Sun Jian-Mei; Shen Jian-Guo; Jin Ji-Zhong; Liu Feng; Xu Xiao-Lin; Chen Lin; Liu Lin-Tao; Lv Jia-Ju | |
刊名 | Oncology letters
![]() |
2015 | |
卷号 | 10期号:4 |
关键词 | G0 phase LIM domain kinase 1 LNCaP cells PC-3 cells afzelin prostate cancer |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4269966 |
专题 | 上海健康医学院 |
推荐引用方式 GB/T 7714 | Zhu Kai-Chang,Sun Jian-Mei,Shen Jian-Guo,et al. Afzelin exhibits anti-cancer activity against androgen-sensitive LNCaP and androgen-independent PC-3 prostate cancer cells through the inhibition of LIM domain kinase 1.[J]. Oncology letters,2015,10(4). |
APA | Zhu Kai-Chang.,Sun Jian-Mei.,Shen Jian-Guo.,Jin Ji-Zhong.,Liu Feng.,...&Lv Jia-Ju.(2015).Afzelin exhibits anti-cancer activity against androgen-sensitive LNCaP and androgen-independent PC-3 prostate cancer cells through the inhibition of LIM domain kinase 1..Oncology letters,10(4). |
MLA | Zhu Kai-Chang,et al."Afzelin exhibits anti-cancer activity against androgen-sensitive LNCaP and androgen-independent PC-3 prostate cancer cells through the inhibition of LIM domain kinase 1.".Oncology letters 10.4(2015). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论